RESUMO
Background and Aim: The value of the pet food industry, which is majorly the prescribed diet, exponentially increased over the years due to increased awareness among pet owners to provide a healthy lifestyle for their pets. However, several factors such as aroma, flavor, texture, and shape of prescribed diets greatly influenced the palatability in cats. Therefore, this study aimed to determine the palatability of the prescribed diet for domestic shorthair (DSH) cats. Materials and Methods: The two-bowl method was employed to determine the palatability of prescribed diets on five DSH cats for 6 days. Furthermore, the four types of prescribed diet assessed in this study were struvite, renal, hypersensitivity, and intestinal. Furthermore, the pet food palatability was analyzed using "First Approached," "First Consumed," "Total Consumption," and "Intake ratios." Results: Our findings revealed that "Total Consumption" and "Intake Ratios" were significantly different in struvite, renal, and intestinal diets compared to the hypersensitivity diet. In addition, this result indicates that the hypersensitivity diet is the most unpalatable compared with other diets. Conclusion: A detailed investigation of the diet ingredients showed that a hypersensitivity diet lacks herbs and spices than the other diets. Therefore, these ingredients lacking in the hypersensitivity diet influence the palatability of pet foods.
RESUMO
Stevia rebaudiana Bertoni is a native plant to Paraguay. The extracts have been used as a famous sweetening agent, and the bioactive components derived from stevia possess a broad spectrum of therapeutical potential for various illnesses. Among its medicinal benefits are anti-hypertensive, anti-tumorigenic, anti-diabetic, and anti-hyperlipidemia. Statins (3-hydro-3-methylglutaryl-coenzyme A reductase inhibitor) are a class of drugs used to treat atherosclerosis. Statins are explicitly targeting the HMG-CoA reductase, an enzyme in the rate-limiting step of cholesterol biosynthesis. Despite being widely used in regulating plasma cholesterol levels, the adverse effects of the drug are a significant concern among clinicians and patients. Hence, steviol glycosides derived from stevia have been proposed as an alternative in replacing statins. Diterpene glycosides from stevia, such as stevioside and rebaudioside A have been evaluated for their efficacy in alleviating cholesterol levels. These glycosides are a potential candidate in treating and preventing atherosclerosis provoked by circulating lipid retention in the sub-endothelial lining of the artery. The present review is an effort to integrate the pathogenesis of atherosclerosis, involvement of lipid droplets biogenesis and its associated proteins in atherogenesis, current approaches to treat atherosclerosis, and pharmacological potential of stevia in treating the disease.
